1. Home
  2. MXC vs BRNS Comparison

MXC vs BRNS Comparison

Compare MXC & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MXC

Mexco Energy Corporation

HOLD

Current Price

$8.76

Market Cap

20.8M

Sector

Energy

ML Signal

HOLD

Logo Barinthus Biotherapeutics plc

BRNS

Barinthus Biotherapeutics plc

N/A

Current Price

$0.70

Market Cap

24.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MXC
BRNS
Founded
1972
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.8M
24.1M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
MXC
BRNS
Price
$8.76
$0.70
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
8.8K
22.0K
Earning Date
02-10-2026
05-07-2026
Dividend Yield
1.02%
N/A
EPS Growth
30.65
N/A
EPS
0.30
N/A
Revenue
$2,705,235.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$29.20
N/A
Revenue Growth
7.12
N/A
52 Week Low
$6.75
$0.51
52 Week High
$16.48
$2.91

Technical Indicators

Market Signals
Indicator
MXC
BRNS
Relative Strength Index (RSI) 39.26 61.01
Support Level $8.57 $0.66
Resistance Level $9.65 $0.76
Average True Range (ATR) 0.49 0.06
MACD -0.04 0.00
Stochastic Oscillator 0.57 80.20

Price Performance

Historical Comparison
MXC
BRNS

About MXC Mexco Energy Corporation

Mexco Energy Corporation is an independent oil and gas company. It is engaged in the acquisition, exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 for chronic hepatitis B using viral vector platform technologies, aimed at inducing disease-specific immune responses.

Share on Social Networks: